Doravirine/islatravir just as effective as Biktarvy in previously untreated people
Novel drugs that turn HIV against itself might clear infected cells from the body
Dolutegravir alone maintains HIV suppression in those treated early
Thigh injections could be an option for long-acting cabotegravir and rilpivirine
Top 5 stories on injectable HIV treatment and PrEP from CROI 2023
Top 5 stories on new drugs for HIV prevention and treatment from CROI 2023
Lenacapavir plus broadly neutralising antibodies may offer twice-yearly treatment option
White blood cell changes on islatravir do not lead to a higher risk of infections
‘Real world’ injectable treatment halves patient dissatisfaction, with only two viral failures in first six months
